. There are gaps and challenges to be addressed in the fight against HIV and AIDS.
HIV/AIDS surveillance methods evolve over time, so data from the same source may not be directly comparable year to year. The type of data available and the lag-time in availability, may pose challenges to assessing recent impact. Epidemiological measures of HIV/AIDS are numerous and each has important and distinct definitions. Much of the data are estimates only. This is true globally and in all countries, even the United States, due to the lag-time between HIV infection and the development of AIDS, the fact that many do not know their status, stigma which leads to under reporting, and surveillance systems that may not be complete. Attention should be given to ranges given around any estimate, as well as any notes that may accompany data, since these may provide important information that can help in your interpretation. Rates/percents, not just numbers, are important.
In 2001, the UNAIDS/WHO introduced a new version of its epidemiological model for all developing countries. The model known as Estimation and Projection Package (EPP) makes use of the surveillance data from each HIV sentinel site in estimating HIV/AIDS prevalence rates. The Spectrum Program also utilizes the information on the birth rate, death rate and the output of EPP for the country in calculating the estimated number of people living with HIV, number of new infections, number of AIDS cases, number of AIDS deaths, number of orphans, etc. The extent to which this data source is representative of the entire adult population of Nepal is doubtful. This is because not all pregnant women attended antenatal clinics and not all women of adult age were pregnant at the time of the surveys. The selection procedure of the survey sites also systematically excludes private clinics where many births occur. The Spectrum Program of UNAIDS and WHO makes use of vital rates which were obtained from a poor vital registration system. Therefore, national estimates based on these surveys rely on a fraction of women who attended the selected antenatal clinics.
Focusing on the epidemiology of HIV/AIDS in Nepal, some studies have been published, but nothing has been done in the area of modelling the course of the infection overtime. Infectious disease data has two features that distinguish it from other data. It is highly dependent on the chosen treatment modalities and the process of infection is only partially observable 3 . A consequence of these features is that the analysis of data is usually most effective when it is based on a model that describes aspects of the infection process Becker and Britton (1999). Again, an understanding of the magnitude and trajectory of the HIV/AIDS epidemic, as well as the uncertainty around the parameters is critically important both for planning and evaluating control strategies and for preparing for vaccine efficacy trials 4 . Mathematical models can become very useful tools in this area. Therefore modelling is an integral part of statistical work in HIV/AIDS research.
Modelling exercises are additionally aimed at making use of the available data (no matter how little) to provide information about the trend inherent in the course of the epidemic. Since, in Nepal, data on HIV/AIDS are scanty, a better insight can be provided if analysis of the data is based on estimate of statistical models whose assumption are realistic and with parameters defined to capture the situations peculiar to the locality. One such statistical models is the back-calculation method that was first proposed by Brookmeyer and Gail (1986) for estimating infection distribution and for providing short-term projection of future AIDS case 5, 6 . Back-calculation is a method for estimating past infection rates from AIDS incidence data. The method has been useful for obtaining short term projections of AIDS incidence and estimating HIV prevalence. Back-calculation requires reliable counts of the numbers of AIDS cases diagnosed over time and a reliable estimate of the incubation period distribution. Early references on back-calculation are Brookmeyer and Gail 5, 7 .
The basic idea is to use AIDS incidence data together with an estimate of the incubation period distribution to reconstruct the numbers of individuals who must have been previously infected in order to give rise to the observed pattern of AIDS incidence. Then, the incubation distribution is applied to these estimated numbers of previously infected individuals to project AIDS incidence.
The fundamental relation between the expected cumulative number of AIDS cases diagnosed by calendar time t, A(t), the infection rate g(s) at calendar time s, and the incubation period distribution F(t), is given by the convolution equation Back Calculation formula is A(t)= the cumulative HIV cases at time t g(S)= infection rate at time s F(t-s)= the weibull distribution function for the incubation of the people who lives after the time s to t.
The convolution equation (1) is justified by noting that in order for an individual to be diagnosed by calendar time t, he or she must have been infected at some prior time s and then have an incubation period less than t -s. Essentially, the back-calculation methodology uses equation (1) together with knowledge of A(t) (obtained from registries of AIDS cases) and F(t) (obtained from epidemiological studies) to glean information about previous infection rates g(s).
Talking about the models for incubation time period of HIV, it is the random time between the HIV infection and the onset of clinical AIDS symptoms. The probability distribution of this non negative random variable is known as HIV incubation period distribution. Back calculation methods are very sensitive to incubation time distribution so we have to find out a best fitted model for the incubation time of HIV. Some most used models are Weibull and Gamma models, Log logistic and Log normal models, Mixture and Staging Model, Change point and Contact Models [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] .
The limitations of studies which consist only of AIDS cases, such as the transfusion study, called attention to the importance of following cohorts of infected individuals to monitor their immune systems and to determine progression rates to AIDS. One rapid and convenient study design involves assembling a cohort of individuals who are already HIV seropositive but whose dates of seroconversion are typically unknown. These are called prevalent cohort studies. A number of statistical problems arise in the interpretation and analysis of prevalent cohorts.
Given the observed limitations in the current estimation procedures in Nepal, it is better to examine other modelling approaches for HIV/AIDS epidemic (Sathian B et al, 2011) that could be more suitable and give more accurate estimates for the Nepal epidemic scenario 
